{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:40:29Z","timestamp":1793914829443,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Vet Scand"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe economic losses worldwide and only four countries in Europe are free from PRRSV. Complete depopulation\u2013repopulation is the safest and fastest, but also the most expensive method for eradicating PRRSV from a population. Another possible way to eliminate an endemic PRRSV infection is to replace the infected breeding stock by gilts reared isolated and protected from PRRSV on an infected farm. With this method it is possible to maintain continuous production on the farm. The authors report the first successful elimination of PRRSV in a Hungarian large-scale pig farm by using an inactivated vaccine and performing segregated rearing of the offspring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>The study was performed on a PRRSV infected farm (Farm A) with 1475 sows. The clinical signs of reproductive failure had been eliminated previously by using an inactivated vaccine (Progressis<jats:sup>\u00ae<\/jats:sup>, Ceva). At the beginning of the elimination programme, gilts intended for breeding were vaccinated at 60 and 90\u2013100\u00a0days of age. After that, gilts selected for breeding were vaccinated at 6\u00a0months of age, on the 60\u201370th day of pregnancy and at weaning.<\/jats:p><jats:p>Approximately 1200 piglets from vaccinated sows were transported at 7\u00a0weeks of age to a closed, empty farm (Farm B) after being tested negative for PRRSV by a polymerase chain reaction (PCR) method, and then were reared here until 14\u00a0weeks of age. At this age, all pigs were tested by PRRS ELISA. Seronegative gilts (n\u2009=\u2009901) were subsequently transported from Farm B to a third, closed and empty farm (Farm C), and (having reached the breeding age) they were inseminated here after a second negative serological test (ELISA). At the same time, Farm A was depopulated, cleaned and disinfected. All pregnant gilts were transported from Farm C to Farm A after being re-tested negative for antibodies against PRRSV. Follow-up serology tests were performed after farrowing and results yielded only seronegative animals. Based on the subsequent negative test results, the herd was declared PRRSV free by the competent authority.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The presented farm was the first during the National PRRS Eradication Programme of Hungary to eradicate PRRSV successfully by vaccinating the sows with an inactivated vaccine and performing segregated rearing of the offspring. Production was almost continuous during the whole process of population replacement.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13028-022-00630-5","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T10:04:59Z","timestamp":1651917899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Elimination of porcine reproductive and respiratory syndrome virus infection using an inactivated vaccine in combination with a roll-over method in a Hungarian large-scale pig herd"],"prefix":"10.1186","volume":"64","author":[{"given":"Attila","family":"Pertich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Barna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Makai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"B\u00e1lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3985-2617","authenticated-orcid":false,"given":"Mih\u00e1ly","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"630_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.54846\/jshap\/754","volume":"21","author":"DJ Holtkamp","year":"2013","unstructured":"Holtkamp DJ, Kliebenstein JB, Neumann E, Zimmerman JJ. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J Swine Health Prod. 2013;21:72\u201384.","journal-title":"J Swine Health Prod"},{"key":"630_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.7774\/cevr.2016.5.1.70","volume":"5","author":"L Jung-Ah","year":"2016","unstructured":"Jung-Ah L, Nak-Hyung L, Joong-Bok L, Seung-Yong P, Chang-Seon S, In-Soo C, et al. Augmented immune responses in pigs immunized with an inactivated porcine reproductive and respiratory syndrome virus containing the deglycosylated glycoprotein 5 under field conditions. Clin Exp Vaccine Res. 2016;5:70\u20134.","journal-title":"Clin Exp Vaccine Res"},{"key":"630_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40813-016-0037-y","volume":"2","author":"G Balka","year":"2016","unstructured":"Balka G, Dreckmann K, Papp G, Kraft C. Vaccination of piglets at 2 and 3 weeks of age with Ingelvac PRRSFLEX\u00ae EU provides protection against heterologous field challenge in the face of homologous maternally derived antibodies. Porc Health Manag. 2016;2:24. https:\/\/doi.org\/10.1186\/s40813-016-0037-y.","journal-title":"Porc Health Manag."},{"key":"630_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.prevetmed.2018.02.005","volume":"152","author":"H Nathues","year":"2018","unstructured":"Nathues H, Alarcon P, Rushton J, Jolie R, Fiebig K, Jimenez M, et al. Modelling the economic efficiency of using different strategies to control porcine reproductive & respiratory syndrome at herd level. Prev Vet Med. 2018;152:89\u2013102.","journal-title":"Prev Vet Med"},{"key":"630_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40813-017-0058-1","volume":"3","author":"P Berton","year":"2017","unstructured":"Berton P, Normand V, Martineau GP, Bouchet F, Lebret A, Waret-Szkuta A. Evaluation of porcine reproductive and respiratory syndrome stabilization protocols in 23 French Farrow-to-finish farms located in a high-density swine area. Porc Health Manag. 2017;3:11. https:\/\/doi.org\/10.1186\/s40813-017-0058-1.","journal-title":"Porc Health Manag"},{"key":"630_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40813-016-0038-x","volume":"2","author":"G Cano","year":"2016","unstructured":"Cano G, Cavalcanti MO, Orveillon FX, Kroll J, Gomez-Duran O, Morillo A, et al. Production results from piglets vaccinated in a field study in Spain with a Type 1 porcine respiratory and reproductive virus modified live vaccine. Porc Health Manag. 2016;2:22. https:\/\/doi.org\/10.1186\/s40813-016-0038-x.","journal-title":"Porc Health Manag"},{"key":"630_CR7","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3389\/fmicb.2017.01635","volume":"8","author":"Y Nan","year":"2017","unstructured":"Nan Y, Wu C, Gu G, Sun W, Zhang Y-J, Zhou E-M. Improved vaccine against PRRSV: current progress and future perspective. Front Microbiol. 2017;8:1635.","journal-title":"Front Microbiol"},{"key":"630_CR8","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/tbed.13555","volume":"67","author":"LK Kvisgaard","year":"2020","unstructured":"Kvisgaard LK, Kristensen CS, Ryt-Hansen P, Pedersen K, Stadejek T, Trebbien R, et al. A recombination between two Type 1 Porcine reproductive and respiratory syndrome virus (PRRSV-1) vaccine strains has caused severe outbreaks in Danish pigs. Transbound Emerg Dis. 2020;67:1786\u201396. https:\/\/doi.org\/10.1111\/tbed.13555.","journal-title":"Transbound Emerg Dis"},{"key":"630_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5501\/wjv.v1.i1.23","volume":"12","author":"W Charerntantanakul","year":"2012","unstructured":"Charerntantanakul W. Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects. World J Virol. 2012;12:23\u201330.","journal-title":"World J Virol"},{"key":"630_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1439-0450.2006.00965.x","volume":"53","author":"VG Papatsiros","year":"2006","unstructured":"Papatsiros VG, Alexopoulos C, Kritas SK, Koptopoulos G, Nauwynck HJ, Pensaert MB, et al. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows. J Vet Med B. 2006;53:266\u201372.","journal-title":"J Vet Med B"},{"key":"630_CR11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3389\/fimmu.2019.01689","volume":"10","author":"M Toman","year":"2019","unstructured":"Toman M, Celer V, Kavanov\u00e1 L, Lev\u00e1 L, Frolichova J, Ondr\u00e1ckov\u00e1 P, et al. Dynamics and differences in systemic and local immune responses after vaccination with inactivated and live commercial vaccines and subsequent subclinical infection with PRRS virus. Front Immunol. 2019;10:1689.","journal-title":"Front Immunol"},{"key":"630_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40813-016-0019-0","volume":"2","author":"J Alvarez","year":"2016","unstructured":"Alvarez J, Valdes-Donoso P, Tousignant S, Alkhamis M, Morrison R, Perez A. Novel analytic tools for the study of porcine reproductive and respiratory syndrome virus (PRRSv) in endemic settings: lessons learned in the U.S. Porc Health Manag. 2016;2:3.","journal-title":"Porc Health Manag"},{"key":"630_CR13","unstructured":"Vansickle, J. PRRS elimination final goal. Position statement of the board of directors of the American Association of Swine Veterinarians (AASV). https:\/\/www.nationalhogfarmer.com\/mag\/farming_prrs_elimination_final. 2015."},{"key":"630_CR14","unstructured":"Scottish Agricultural Organisation Society Ltd. Scottish Porcine Reproductive and Respiratory Syndrome Elimination Project. http:\/\/www.saossupplychains.scot\/scottish-prrs-elimination-project\/. 2018."},{"key":"630_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13028-016-0270-z","volume":"59","author":"PH Rathkjen","year":"2017","unstructured":"Rathkjen PH, Dall J. Control and eradication of porcine reproductive and respiratory syndrome virus type 2 using a modified-live type 2 vaccine in combination with a load, close, homogenise model: an area elimination study. Acta Vet Scand. 2017;59:4. https:\/\/doi.org\/10.1186\/s13028-016-0270-z.","journal-title":"Acta Vet Scand"},{"key":"630_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0167-5877(03)00081-3","volume":"60","author":"G Nodelijk","year":"2003","unstructured":"Nodelijk G, Nielen M, De Jong MCM, Verheijden JHM. A review of porcine reproductive and respiratory syndrome virus in Dutch breeding herds: population dynamics and clinical relevance. Prev Vet Med. 2003;60:37\u201352.","journal-title":"Prev Vet Med"},{"key":"630_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1556\/004.2019.053","volume":"67","author":"I Nemes","year":"2019","unstructured":"Nemes I, Moln\u00e1r T, Abonyi T, Terj\u00e9k Zs, B\u00e1lint \u00c1, Szab\u00f3 I. Eradication of PRRS from backyard swine herds in Hungary between 2012 and 2018. Acta Vet Hung. 2019;67:543\u201352.","journal-title":"Acta Vet Hung"},{"key":"630_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1556\/004.2019.052","volume":"67","author":"I Szab\u00f3","year":"2019","unstructured":"Szab\u00f3 I, Moln\u00e1r T, Nemes I, Abonyi T, Terj\u00e9k Zs, B\u00e1lint \u00c1. PRRS eradication on large-scale fattening pig farm sin Hungary between 2014 and 2019. Acta Vet Hung. 2019;67:529\u201342.","journal-title":"Acta Vet Hung"},{"key":"630_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.17221\/68\/2017-VETMED","volume":"62","author":"M Toman","year":"2017","unstructured":"Toman M, Celer V, Smola J. Successful elimination of PRRS virus from an infected farrow-to-finish herd by vaccination. Vet Med. 2017;62:553\u20138.","journal-title":"Vet Med"},{"key":"630_CR20","unstructured":"Stricker A. Why PRRS elimination doesn\u2019t work in some herds. https:\/\/www.thepigsite.com\/news\/2017\/10\/why-prrs-elimination-doesnt-work-in-some-herds-1."},{"key":"630_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40813-019-0134-9","volume":"5","author":"D Torrents","year":"2019","unstructured":"Torrents D, Miranda J, Pedrazuela R, Gauger PC, Ramirez A, Linhares DCL. Implementation of PRRSV status classification system in swine breeding herds from a large integrated group in Spain. Porc Health Manag. 2019;5:26. https:\/\/doi.org\/10.1186\/s40813-019-0134-9.","journal-title":"Porc Health Manag"},{"key":"630_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.prevetmed.2014.05.010","volume":"116","author":"DCL Linhares","year":"2014","unstructured":"Linhares DCL, Cano JP, Torremorell M, Morrison RB. Comparison of time to PRRSv-stability and production losses between two exposure programs to control PRRSv in sow herds. Prev Vet Med. 2014;116:111\u20139.","journal-title":"Prev Vet Med"},{"key":"630_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1948-5948.1000387","volume":"10","author":"PH Rathkjen","year":"2018","unstructured":"Rathkjen PH, Dall J. Maximising the chances of success for PRRSV area-regional control and elimination programmes: a 5-step process in practice. J Microb Biochem Technol. 2018;10:1. https:\/\/doi.org\/10.4172\/1948-5948.1000387.","journal-title":"J Microb Biochem Technol"},{"key":"630_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2010.10.009","volume":"154","author":"JK Lunney","year":"2010","unstructured":"Lunney JK, Benfield DA, Rowland RR. Porcine reproductive and respiratory syndrome virus: an update on an emerging and re-emerging viral disease of swine. Virus Res. 2010;154:1\u20136.","journal-title":"Virus Res"},{"key":"630_CR25","first-page":"20","volume":"1","author":"SA Dee","year":"1993","unstructured":"Dee SA, Morrison RB, Joo H. Eradicating porcine reproductive and respiratory syndrome (PRRS) virus using two-site production and nursery depopulation. Swine Health Prod. 1993;1:20\u20133.","journal-title":"Swine Health Prod"},{"key":"630_CR26","first-page":"157","volume-title":"Managing Pig Health A Reference for the Farm","author":"MR Muirhead","year":"2013","unstructured":"Muirhead MR, Alexander TJL, Carr J. Reproduction: noninfectious infertility. In: Muirhead MR, Alexander TJL, Carr J, editors. Managing Pig Health A Reference for the Farm. Sheffield, 5M Enterprises Limited; 2013. p. 157\u201398."}],"container-title":["Acta Veterinaria Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-022-00630-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13028-022-00630-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-022-00630-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T01:26:46Z","timestamp":1727141206000},"score":1,"resource":{"primary":{"URL":"https:\/\/actavetscand.biomedcentral.com\/articles\/10.1186\/s13028-022-00630-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1186\/s13028-022-00630-5","relation":{},"ISSN":["1751-0147"],"issn-type":[{"value":"1751-0147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. MA is employee of Ceva Phylaxia, the producer of the vaccine used (Progressis<sup>\u00ae<\/sup>).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}